Impaired cognitive performance in ornithine transcarbamylase-deficient mice on arginine-free diet

Brain Research

Volumn 876, Issue 1-2, 2000, Pages 1-9

  D'Hooge, R ^a,b   Marescau, B ^a   Qureshi, I A ^c   De Deyn, P P ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Hyperammonaemia; Morris water maze; Ornithine transcarbamylase deficiency; Passive avoidance learning; Sparse fur mouse

Indexed keywords

AMMONIA; ARGININE; ORNITHINE CARBAMOYLTRANSFERASE;

AMINO ACID METABOLISM; AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DIETARY INTAKE; ENZYME DEFICIENCY; FEMALE; HYPERAMMONEMIA; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SCANTY HAIR; UREA CYCLE;

AMMONIA; ANIMALS; ARGININE; AVOIDANCE LEARNING; COGNITION DISORDERS; DIET; MAZE LEARNING; MICE; MICE, MUTANT STRAINS; ORNITHINE CARBAMOYLTRANSFERASE; REFERENCE VALUES; RETENTION (PSYCHOLOGY); SWIMMING;

EID: 0034623174     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02589-0     Document Type: Article

References (24)

1. Batshaw M.L., Hyman S.L., Mellits E.D., Thomas G.H., DeMuro R., Coyle J.T. Behavioral and neurotransmitter changes in the urease-infused rat, a model of congenital hyperammonemia. Pediatr. Res. 20:1986;1310-1315.
2. Batshaw M.L., Hyman S.L., Bachmann C., Qureshi I.A., Coyle J.T. Animal models of congenital hyperammonemia. Coyle J.T. Animal Models of Dementia. 1987;163-198 Liss, New York.
3. Batshaw M.L., Yudkoff M., McLaughlin B.A., Gorry E., Anegawa N.J., Smith I.A.S., Hyman S.L., Robinson M.B. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency. Gene Ther. 2:1995;743-749.
4. Butterworth R.F. Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency. Dev. Neurosci. 20:1998;478-484.
5. DeMars R., LeVan S.L., Trend B.L., Russell L.B. Abnormal ornithine carbamoyltransferase in mice having the sparse-fur mutation. Proc. Natl. Acad. Sci. USA. 73:1976;1693-1697.
6. Dienst S.G. An ion exchange method for plasma ammonia concentration. J. Lab. Clin. Med. 58:1961;149-155.
7. Erecinska A., Pastuszko A., Wilson D.F., Nelson D. Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J. Neurochem. 49:1987;1258-1265.
8. Gibson G.E., Zimber A., Krook L., Richardson E.P., Visek W.J. Brain histology and behavior of mice injected with urease. J. Neuropathol. Exp. Neurol. 33:1974;201-211.
9. W-nitro-L-arginine. Eur. J. Pharmacol. 341:1998;1-9.
10. W-nitro-L-arginine in rats impairs learning in a 14-unit T-maze. Eur. J. Pharmacol. 341:1998;11-16.
11. Inoue I., Gushiken T., Kobayashi K., Saheki T. Accumulation of large neutral amino acids in the brain of sparse-fur mice at hyperammonemic state. Biochem. Med. Metab. Biol. 38:1987;378-386.
12. Maestri N.E., Clissold D., Brusilow S.W. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J. Pediatr. 134:1999;268-272.
13. Meyer R.C., Spangler E.L., Patel N., London E.D., Ingram D.K. Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur. J. Pharmacol. 341:1998;17-22.
14. Msall M., Batshaw M.L., Suss R., Brusilow S.W., Mellits E.D. Neurologic outcome in children with inborn errors of urea synthesis. N. Engl. J. Med. 310:1984;1500-1505.
15. Nagata N., Matsuda I., Matsuura T., Oyanagi K., Tada K., Narisawa K., Kitagawa T., Sakiyama T., Yamashita F., Yoshino M. Retrospective study of urea cycle disorders. Part 2: Neurological outcome in forty-nine Japanese patients with urea cycle enzymopathies. Am. J. Med. Genet. 40:1991;477-481.
16. Qureshi I.A., Letarte J., Ouellet R. Ornithine transcarbamylase deficiency in mutant mice. I. Studies on the characterization of enzyme defect and suitability as animal model of human disease. Pediatr. Res. 13:1979;807-811.
17. Qureshi I.A., Letarte J., Ouellet R. Spontaneous animal models of ornithine transcarbamylase deficiency, studies on serum and nitrogen metabolites. Lowenthal A., Mori A., Marescau B. Urea Cycle Diseases. 1983;173-183 Plenum Press, New York.
18. Qureshi I.A., Rama Rao K.V. Sparse-fur (spf) mouse as a model of hyperammonemia, alterations in the neurotransmitter systems. Adv. Exp. Med. Biol. 420:1997;143-158.
19. Ratnakumari L., Qureshi I.A., Butterworth R.F., Marescau B., De Deyn P.P. Arginine-related guanidino compounds and nitric oxide synthase in the brain of ornithine trnascarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency. Neurosci. Lett. 215:1996;153-156.
20. Ricciuti F., Gelehrter T.D., Rosenberg L.E. X-Chromosome inactivation in human liver, confirmation of X-linkage of ornithine transcarbamylase. Am. J. Hum. Genet. 28:1976;332-338.
21. Telegdy G., Kokavszky R. The role of nitric oxide in passive avoidance learning. Neuropharmacology. 36:1997;1583-1587.
22. Thoene J.G. Treatment of urea cycle disorders. J. Pediatr. 134:1999;255-256.
23. Veres G., Gibbs R.A., Scherer S.E., Caskey C.T. The molecular basis of the sparse fur mouse mutation. Science. 237:1987;415-417.
24. Zou L.B., Yamada K., Tanaka T., Kameyama T., Nabeshima T. Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology. 37:1998;323-330.